Trial Profile
Effects of Galantamine and Donepezil on the Amount and the Quality on the Sleep in Patients Suffering From Alzheimer Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2014
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 04 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Sep 2013 Planned end date changed from 1 Sep 2009 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.